Biotech for the 21st Century: Release of Administration Report

Ray Dobert rdobert at nalusda.gov
Fri Nov 10 00:33:59 EST 1995


(Washington DC, November 9, 1995)  -  At a media event announcing 
regulatory reforms at the Food and Drug Administration impacting 
biotechnology drug development, Vice President Al Gore and the President's 
Science Advisor, Dr. Jack Gibbons announced the release of a report entitled

	BIOTECHNOLOGY FOR THE 21ST CENTURY: NEW HORIZONS

The 90-page report was prepared by the National Science and Technology
Council's Biotechnology Research Subcommittee and describes the federal
investment in biotechnology and identifies research priorities and
opportunities for the future. 

To reach as broad an audience as possible, in addition to the print
format, the report is available via the WWW at:
	http://www.nalusda.gov/bic/bio21/ 
or alternatively via that NSTC Homepage at:
	http://www.whitehouse.gov/White_House/EOP/OSTP/NSTC/html/NSTC_Home.html

In discussing the new report the Vice President stated, "this report, a
product of planning and coordination through the National Science and
Technology Council, lays out priorities for future investment in research
to enable the contributions of biotechnology in emerging areas beyond
health--in agriculture, environmental remediation, bioprocessing
approaches to manufacturing, and in applications of biotechnology to
preserve and utilize marine resources." 

Dr. Gibbons added "the collection of techniques that have come to be known
as biotechnology--the use of restriction enzymes to cut and splice DNA and
RNA, early sequencing technology, and regulation of gene expression-- are
largely the result of research in fundamental biology that was supported
by the Federal government.  The research at the very beginning of the
product development pipeline, with broad utility across the entire
spectrum of biotechnology applications, remains well within the domain of
programs supported by 13 Executive branch agencies." 

"Under the purview of the National Science and Technology Council, these
agencies conducted an extensive 18-month examination of their
biotechnology research portfolios.  Today, I am pleased to present the
product of their efforts, Biotechnology for the 21st Century:  New
Horizons.  This report identifies the leading priorities for Federal
investment in biotechnology research beyond health, and describes a number
of specific scientific opportunities.  The areas that were examined are: 
agriculture, environment, manufacturing and bioprocessing, and marine
biotechnology and aquaculture."


 






More information about the Bionews mailing list